Nanotechnology-Based Strategies for Safe and Effective Immunotherapy
Author Information
Author(s): Hong Seeun, Park Juwon, Oh Yoojeong, Cho Hanhee, Kim Kwangmeyung
Primary Institution: Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea
Hypothesis
Can nanoparticles enhance the efficacy of immunotherapy by inducing immunogenic cell death and remodeling the tumor microenvironment?
Conclusion
Nanoparticle-based strategies can effectively induce immunogenic cell death and remodel the tumor microenvironment, improving the efficacy of cancer immunotherapy.
Supporting Evidence
- Nanoparticles can enhance drug efficacy by improving targeting efficiency and minimizing non-specific toxicity.
- Inducing immunogenic cell death can help activate the immune system against tumors.
- Combining different therapies with nanoparticles can lead to better treatment outcomes in cancer immunotherapy.
Takeaway
This study shows that tiny particles called nanoparticles can help cancer treatments work better by making cancer cells die in a way that helps the immune system fight the cancer.
Methodology
The review discusses various studies integrating chemotherapy, radiation therapy, photodynamic therapy, and photothermal therapy with nanoparticle-based immunotherapy.
Limitations
The review does not provide specific experimental data or sample sizes, limiting the ability to assess the strength of the evidence presented.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website